Siontis, George Cm; Sweda, Romy; Windecker, Stephan (2020). Cardiovascular clinical trials in the era of a pandemic. Journal of the American Heart Association, 9(20), e018288. American Heart Association 10.1161/JAHA.120.018288
|
Text
Cardiovascular clinical trials in the era of a pandemic.pdf - Accepted Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (3MB) | Preview |
COVID-19 has reached pandemic levels in March 2020 and impacted public health with unpredictable consequences.1, 2 The conduct of clinical research in areas unrelated to COVID-19 has been disrupted and will be further affected. Researchers, trial participants and study personnel have to overcome challenges to sustain proper and safe conduct of clinical trials (i.e. logistical challenges, lower enrollment than expected, difficulties in follow-up and outcome assessment/adjudication, incomplete data collection, research funding prolongation).
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology |
UniBE Contributor: |
Siontis, Georgios, Sweda, Romy, Windecker, Stephan |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2047-9980 |
Publisher: |
American Heart Association |
Language: |
English |
Submitter: |
Nadia Biscozzo |
Date Deposited: |
29 Nov 2020 15:16 |
Last Modified: |
05 Dec 2022 15:41 |
Publisher DOI: |
10.1161/JAHA.120.018288 |
PubMed ID: |
32993467 |
Uncontrolled Keywords: |
COVID‐19 cardiovascular disease cardiovascular research randomized controlled trial |
BORIS DOI: |
10.7892/boris.147490 |
URI: |
https://boris.unibe.ch/id/eprint/147490 |
Actions (login required)
 |
Edit item |